نتایج جستجو برای: gardasil

تعداد نتایج: 213  

2017
Francesco Saverio Mennini Paolo Bonanni Florence Bianic Chiara de Waure Gianluca Baio Giacomo Plazzotta Mathieu Uhart Alessandro Rinaldi Nathalie Largeron

BACKGROUND In Italy HPV vaccination with the quadrivalent vaccine (Gardasil®) is offered actively and free of charge to girls aged 12 since 2007. A nine-valent vaccine (Gardasil 9®) received the European market authorization in 2015 to protect, with only 2 doses, against around 90% of all HPV positive cancers, over 80% of high-grade precancerous lesions and 90% of genital warts caused by HPV ty...

Journal: :Revista medica de Chile 2008
Katia Abarca M Teresa Valenzuela Rodrigo Vergara Vivian Luchsinger Alma Muñoz Jorge Jiménez de la J Erna Ripoll Miguel O'Ryan

This article briefly reviews the epidemiology of human papillomavirus (HPV) infection and associated diseases globally and in Chile, and the scientific information of the licensed HPV vaccines: Gardasil and Cervari. Considering the available information, the Advisory Committee on Immunizations of the Chilean Society of Infectious Diseases recommends vaccination of teenage girls, ideally before ...

Journal: :Journal of preventive medicine and hygiene 2008
G Icardi

Since January 2008, the Italian Regions, in accordance with their organizational programme, have launched the offer of free human anti-papillomavirus vaccine (HPV) to 12-year-olds, with the possibility to extend this offer to other age groups. With the beginning of this vaccination campaign, a widespread scientific debate developed concerning certain aspects which are still disputed. In our opi...

2013
VIKRANT C. SANGAR

Human papillomaviruses are the primary etiologic agents of cervical cancer. Thus, cervical cancer and other Human papillomavirus associated malignancies might be prevented by Human papillomavirus vaccines. Currently, two Human papillomavirus L1 Virus -Like Particle vaccines namely Gardasil quadrivalent (Merck) and CervarixTM bivalent (GlaxoSmithKline) are widely marketed internationally. These ...

2013
Loredana Mitran Mihai Mitran Daniela Safta Sorin Puia Carmen Georgescu

Case report We present the possibilities of diagnosis of HPV infection in ENT, and the therapeutic, prophylactic and curative modalities, as well as the assumptions and prevention goals through vaccination within this specialty. We communicate the management of three clinical cases of laryngeal papillomatosis in adults. The first case, a 75-year-old woman, 4 times under surgical intervention wi...

2014
Romain Banchereau Nicole Baldwin Alma-Martina Cepika Shruti Athale Yaming Xue Chun I Yu Patrick Metang Abhilasha Cheruku Isabelle Berthier Ingrid Gayet Yuanyuan Wang Marina Ohouo LuAnn Snipes Hui Xu Gerlinde Obermoser Derek Blankenship Sangkon Oh Octavio Ramilo Damien Chaussabel Jacques Banchereau Karolina Palucka Virginia Pascual

The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize th...

Journal: :Expert review of vaccines 2014
Mitchell Tyler Ebenezer Tumban Bryce Chackerian

The role of HPV as the causative factor in cervical cancer has led to the development of the HPV vaccines Gardasil and Cervarix. These vaccines effectively protect against two HPV types associated with 70% of cervical cancer cases. Despite this success, researchers continue to develop second-generation HPV vaccines to protect against more HPV types and allow increased uptake in developing count...

2013
Kyusun Torque Han Jeong-Im Sin

Human papillomavirus (HPV) infection is a major cause of cervical cancer and its precancerous diseases. Cervical cancer is the second deadliest cancer killer among women worldwide. Moreover, HPV is also known to be a causative agent of oral, pharyngeal, anal and genital cancer. Recent application of HPV structural protein (L1)-targeted prophylactic vaccines (Gardasil® and Cervarix®) is expected...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید